Takeda Development Center Americas recalls
FDA enforcement reports naming Takeda Development Center Americas, Inc. as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Nov 21, 2018
- Nov 21, 2018AMITIZA (lubiprostone) capsules 8 mcgDrug · Takeda Development Center Americas, Inc.Failed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing.Class III
- Oct 17, 2018Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000…Drug · Takeda Development Center Americas, Inc.Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.Class II